Overview
Why was this study done?
The main goal of the study was to see if a third dose of the NTHi Mcat vaccine is safe if it is given 6 or
12 months after the second dose.
What was studied? Who was in this study?
Safety of NTHi Mcat vaccine. 89 women and 111 men from the United
Kingdom, Germany, and Canada took part in
the study. They were 40 to 80 years old
when they got their first vaccination.
What kind of study was it? Main results
Randomized: Adults who joined this This study did not raise any safety
study were assigned to a study group by concerns about NTHi Mcat vaccine.
chance (like tossing a coin).
No study participant withdrew from the
Observer-blind: neither the study staff study because of a vaccine side effect.
nor study participants knew which Approximately 10% of study participants
treatment was given. reported a serious medical event. None
of them were considered to be caused
by the study vaccine.
NCT number: NCT03443427
EudraCT number: 2017-002941-31